GI
MIRM icon

GAMMA Investing’s Mirum Pharmaceuticals MIRM Stock Holding History

GAMMA Investing’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.5K Buy
415
+47
+13% +$4.9K ﹤0.01% 2591
2026
Q2 		$43.1K Buy
368
+35
+11% +$3.51K ﹤0.01% 2399
2026
Q1 		$30.8K Buy
333
+31
+10% +$2.92K ﹤0.01% 2488
2025
Q4 		$23.9K Buy
302
+83
+38% +$5.96K ﹤0.01% 2517
2025
Q3 		$16.1K Buy
219
+74
+51% +$4.7K ﹤0.01% 2638
2025
Q2 		$7.38K Buy
145
+21
+17% +$935 ﹤0.01% 2960
2025
Q1 		$5.59K Buy
124
+4
+3% +$189 ﹤0.01% 3043
2024
Q4 		$4.96K Buy
120
+61
+103% +$2.54K ﹤0.01% 2922
2024
Q3 		$2.3K Buy
59
+49
+490% +$1.96K ﹤0.01% 3028
2024
Q2 		$342 Sell
10
-7
-41% -$184 ﹤0.01% 3263
2024
Q1 		$427 Buy
+17
New +$467 ﹤0.01% 3128

Other funds holding MIRM

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's MIRM Position: Q3 2026 in Review

GAMMA Investing increased its Mirum Pharmaceuticals (MIRM) stake by 13% in Q3 2026, buying an estimated $4.9K and bringing the position to 415 shares worth $35.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2591.

GAMMA Investing first reported a position in MIRM in Q1 2024 and has held it in 11 quarters since. The position peaked at $43.1K in Q2 2026. 6 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • GAMMA Investing held 415 shares of Mirum Pharmaceuticals worth $35.5K as of Q3 2026.
  • GAMMA Investing bought 47 Mirum Pharmaceuticals shares in Q3 2026, an estimated $4.9K.
  • Mirum Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2591 holding.
  • GAMMA Investing first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
  • GAMMA Investing's Mirum Pharmaceuticals position peaked at $43.1K in Q2 2026.
  • 6 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.